Skip to content
AnalystLens

CF Industries Holdings 8-K Report, Regulation FD Disclosure (Jun 24, 2025)

Reports
Regulation FD·Exhibits & Filings
Filing Date
Filed June 24, 2025
Period End
June 24, 2025
Security
CF
In the record · 2016–202610-K1110-Q328-K157

CF filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 157 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Nov ’16Nov ’16
  2. Material agreement8-K · Dec ’19Dec ’19
  3. Leadership change8-K · Dec ’22Dec ’22
  4. Leadership change8-K · Sep ’26Sep ’26

01—Abstract

Summary

Summary of the 8-K filed June 24, 2025. Cited figures are marked; the original filing is the authoritative source.

CF Industries Holdings, Inc. filed this Form 8-K on June 24, 2025 to furnish a presentation (Exhibit 99.1) used at its Investor Day that day.

The filing is a Regulation FD disclosure, and the presentation is not deemed "filed" for Exchange Act purposes. The presentation centers on the company's position as the world's largest ammonia producer, its distribution and logistics advantages in North America, and its decarbonization and low-carbon ammonia strategy, most notably the Blue Point joint venture. Financially, the presentation reports Q1 2025 last-twelve-months (LTM) figures of $2.5 billiona in adjusted EBITDA, $1.6 billion in free cash flow, $1.3 billion in net earnings, $2.4 billion in cash from operations, and $2.0 billion returned to shareholders, with free cash flow conversion of 63% of adjusted EBITDA.

It states a mid-cycle adjusted EBITDA of about $2.5 billionb and projects roughly $3.0 billion of mid-cycle EBITDA around 2030 as Blue Point and decarbonization initiatives contribute. CF also highlights a new $2.0 billion share repurchase authorization running through December 2029 and an estimated CF investment of about $2 billion in Blue Point, with a start-up in 2029 and an expected mid-teens return.

For investors, the key points are the capital allocation framework (returning capital to shareholders while funding Blue Point and capacity growth), the stated balance sheet strength (BBB/Baa2 rating, gross debt to adjusted EBITDA of 1.3xc as of December 31, 2024), and management's assertion that global ammonia demand will outpace supply growth through 2029. These are management projections and forward-looking statements, subject to the risks described in the safe harbor language.

02—Key points

Key Highlights

  1. Presentation furnished under Item 7.01 (Regulation FD) for CF's Investor Day on June 24, 2025; not deemed filed under Section 18 of the Exchange Act
  2. Q1 2025 LTM figures: adjusted EBITDA of $2.5 billion, free cash flow of $1.6 billion, net earnings of $1.3 billion, and cash from operations of $2.4 billion
  3. New $2.0 billion share repurchase authorization set to expire in December 2029, with about $630 million remaining from the Q4 2022 program as of March 31, 2025
  4. Blue Point low-carbon ammonia joint venture: CF's estimated contribution of about $2 billion ($1.5 billion for the ammonia facility plus $550 million for common infrastructure), with start-up in 2029 and a mid-teens expected return
  5. Management projects mid-cycle adjusted EBITDA of about $2.5 billion, rising to roughly $3.0 billion by 2030 with decarbonization and Blue Point contributions
  6. Balance sheet: BBB/Baa2 credit rating, gross debt to adjusted EBITDA of 1.3x as of December 31, 2024, and about $2.3 billion of committed liquidity
  7. Management cites industry demand growth of 12-14 million metric tons (ammonia equivalent) from 2025 to 2029 (ex. China), against 7-8 million metric tons of expected European closures and limited new supply

03—Questions

Frequently Asked Questions

  1. What was disclosed in this 8-K filing?

    The filing furnishes Exhibit 99.1, the presentation CF Industries used at its June 24, 2025 Investor Day. The presentation covers the company's strategy, North American advantages, capital allocation, decarbonization, Blue Point low-carbon ammonia project, and financial metrics. Under Item 7.01, the material is furnished rather than filed for Exchange Act purposes.

  2. How much is CF committing to the Blue Point project?

    The presentation estimates CF's contribution at about $2 billion, consisting of $1.5 billion for the ammonia production facility and $550 million for common, scalable infrastructure. The total Blue Point capital estimate is shown as $4.0 billion, and CF's portion is described as having a mid-teens expected return, with start-up expected in 2029.

  3. What capital return programs does CF highlight?

    CF cites $1.9 billion returned to shareholders in 2024 and about $2.0 billion returned in the Q1 2025 LTM period. It also notes a $2.0 billion share repurchase authorization running through December 2029, and a dividend yield of 2.2%. The presentation says the company's capital allocation targets roughly 60% returned to shareholders and 40% invested in growth over 2010 to Q1 2025.

  4. What do the company's mid-cycle earnings projections look like?

    The presentation states a mid-cycle adjusted EBITDA of about $2.5 billion, based on a NOLA urea price of about $355 per short ton and a CF realized natural gas cost sensitivity. It projects about $3.0 billion of mid-cycle EBITDA by around 2030, driven by $200 million from decarbonization, $300 million from Blue Point, and operational improvements. These are forward-looking management projections subject to the risks in the safe harbor statement.

  5. What risks are noted in the presentation?

    The safe harbor section lists risks including the ability to complete Blue Point on schedule and on budget, the ability to fund capital needs that may exceed current estimates, natural gas price volatility, commodity nitrogen price cyclicality, tariffs and trade measures, weather, reliance on a limited number of key facilities, cybersecurity, and the development of the low-carbon ammonia market and related technologies.

04—Continue

← View all 8-K filings